PL2830662T3 - Sposoby leczenia zaburzeń utraty włosów - Google Patents

Sposoby leczenia zaburzeń utraty włosów

Info

Publication number: PL2830662T3
Authority: PL; Poland
Prior art keywords: methods; hair loss; treating hair; loss disorders; disorders
Prior art date: 2012-03-29

Application number

PL13769804T

Other languages

English (en)

Inventor

Angela M. Christiano

Raphael Clynes

Original Assignee

The Trustees Of Columbia University In The City Of New York

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-03-29

Filing date

2013-03-29

Publication date

2019-02-28

2013-03-29 Application filed by The Trustees Of Columbia University In The City Of New York filed Critical The Trustees Of Columbia University In The City Of New York

2019-02-28 Publication of PL2830662T3 publication Critical patent/PL2830662T3/pl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL13769804T 2012-03-29 2013-03-29 Sposoby leczenia zaburzeń utraty włosów PL2830662T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201261617225P	2012-03-29	2012-03-29
US201261645499P	2012-05-10	2012-05-10
EP13769804.9A EP2830662B1 (en)	2012-03-29	2013-03-29	Methods for treating hair loss disorders
PCT/US2013/034688 WO2013149194A1 (en)	2012-03-29	2013-03-29	Methods for treating hair loss disorders

Publications (1)

Publication Number	Publication Date
PL2830662T3 true PL2830662T3 (pl)	2019-02-28

Family

ID=49261311

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13769804T PL2830662T3 (pl)	2012-03-29	2013-03-29	Sposoby leczenia zaburzeń utraty włosów

Country Status (12)

Country	Link
EP (2)	EP3459565A1 (pl)
JP (2)	JP6212107B2 (pl)
KR (1)	KR102135601B1 (pl)
CN (1)	CN104334191A (pl)
DK (1)	DK2830662T3 (pl)
ES (1)	ES2694681T3 (pl)
HR (1)	HRP20181976T1 (pl)
HU (1)	HUE040127T2 (pl)
PL (1)	PL2830662T3 (pl)
PT (1)	PT2830662T (pl)
SI (1)	SI2830662T1 (pl)
WO (1)	WO2013149194A1 (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3291794A4 (en) *	2015-05-07	2019-02-13	The Trustees of Columbia University in the City of New York	PROCEDURE AND COMPOSITIONS FOR PROMOTING HAIR GROWTH
CN104789689B (zh) *	2015-05-13	2018-10-02	北京泱深生物信息技术有限公司	作为肺腺癌诊治靶标的clec9a基因
CN111606893B (zh)	2015-09-25	2021-05-04	迪哲(江苏)医药股份有限公司	用于抑制jak的化合物和方法
KR20170101724A (ko) *	2016-02-29	2017-09-06	양지화학 주식회사	야누스인산화효소 억제제로서의 치환된 N-(피롤리딘-3-일)-7H-피롤로[2,3-d]피리미딘-4-아민의 용도
CN105695617A (zh) *	2016-04-22	2016-06-22	王冬国	乳头状癌的肿瘤标志物及其应用
HRP20241345T1 (hr)	2016-05-04	2024-12-20	Sun Pharmaceutical Industries, Inc.	Liječenje poremećaja gubitka kose deuteriranim inhibitorima jak
KR20230110373A (ko) *	2016-06-14	2023-07-21	리전츠 오브 더 유니버스티 오브 미네소타	질환을 치료하기 위한 유전적으로 변형된 세포, 조직,및 장기
KR101657082B1 (ko) *	2016-08-08	2016-09-13	에스씨엠생명과학 주식회사	CXCL1(chemokine (C-X-C motif) ligand 1) 단백질을 유효성분으로 포함하는 탈모 예방 또는 치료용 약학적 조성물
RU2019117562A (ru) *	2016-11-10	2020-12-10	Галапагос Нв	Соединения и их фармацевтические композиции для лечения воспалительных заболеваний
US10392368B2 (en)	2017-08-01	2019-08-27	Theravance Biopharma R&D Ip, Llc	Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
US20190142722A1 (en)	2017-11-10	2019-05-16	The Trustees Of Columbia University In The City Of New York	Methods and compositions for promoting or inducing hair growth
KR20210087893A (ko) *	2018-06-04	2021-07-13	케미스트리알엑스.	모발 성장 촉진을 위한 국소 조성물
CA3125039A1 (en)	2019-01-23	2020-07-30	Theravance Biopharma R&D Ip, Llc	Imidazo[1,5-a]pyridine, 1,2,4-triazolo[4,3-a]pyridine and imidazo[1,5-a]pyrazine as jak inhibitors
EP3936624A4 (en) *	2019-03-08	2022-11-23	Neogentc Corp.	MARKER FOR PREDICTING TUMOR REACTIVITY OF LYMPHOCYTES AND THEIR USE
CN111041095B (zh) *	2019-07-11	2021-11-30	江苏医药职业学院	检测8号染色体开放阅读框73表达水平的试剂的应用和试剂盒
KR102187371B1 (ko) *	2019-08-02	2020-12-04	연세대학교 산학협력단	FoxQ1 유전자가 과발현된 지방유래 줄기세포 및 이의 용도
CN115348858A (zh) *	2019-11-08	2022-11-15	凯奇生物公司	使用离子液体的托法替尼表面递送
US11697648B2 (en)	2019-11-26	2023-07-11	Theravance Biopharma R&D Ip, Llc	Fused pyrimidine pyridinone compounds as JAK inhibitors
US12441707B2 (en)	2019-12-30	2025-10-14	Tyra Biosciences, Inc.	Indazole compounds
US20210353600A1 (en) *	2020-05-12	2021-11-18	Chemistryrx	Compositions for treating hair loss
FR3111917B1 (fr) *	2020-06-30	2025-04-11	Oreal	Signature moléculaire d’un état alopécique commun, associée aux jonctions cellulaires
CA3216017A1 (en) *	2021-04-22	2022-10-27	Shengjian Huang	Pharmaceutical composition containing jak3/jak1/tbk1 selective inhibitor and medical use thereof
AU2022328272A1 (en)	2021-08-11	2024-02-22	Sun Pharmaceutical Industries, Inc.	Treatment of hair loss disorders with deuterated jak inhibitors
CN116262136A (zh) *	2021-12-13	2023-06-16	复旦大学附属华山医院	以脯氨酰羟化酶为靶点治疗脱发疾病的药物
TW202345824A (zh) *	2022-03-18	2023-12-01	大陸商四川科倫博泰生物醫藥股份有限公司	氮雜環丁烷衍生物的用途及治療方法
CN114870016B (zh) *	2022-04-21	2023-05-26	上海博悦生物科技有限公司	一种jak抑制剂的微乳泡沫剂及其应用
CN115137832B (zh) *	2022-07-07	2023-11-17	中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所)	一种jak抑制剂的用途及其抗毛霉感染实验方法
FR3143040A1 (fr) *	2022-12-12	2024-06-14	L'oreal	Méthode de pronostic et/ou de diagnostic d’une perte de densité capillaire

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5087240A (en)	1983-08-18	1992-02-11	Drug Delivery Systems Inc.	Transdermal drug patch with conductive fibers
US4921475A (en)	1983-08-18	1990-05-01	Drug Delivery Systems Inc.	Transdermal drug patch with microtubes
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
US4683195A (en)	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5163899A (en)	1987-03-20	1992-11-17	Drug Delivery Systems Inc.	Transdermal drug delivery system
US5312325A (en)	1987-05-28	1994-05-17	Drug Delivery Systems Inc	Pulsating transdermal drug delivery system
US5080891A (en)	1987-08-03	1992-01-14	Ddi Pharmaceuticals, Inc.	Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US5879680A (en)	1987-12-23	1999-03-09	The United States Of America As Represented By The Department Of Health And Human Services	Cloned DNA for synthesizing unique glucocerebrosidase
GB8804164D0 (en)	1988-02-23	1988-03-23	Tucker J M	Bandage for administering physiologically active compound
US5223409A (en)	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
US5008110A (en)	1988-11-10	1991-04-16	The Procter & Gamble Company	Storage-stable transdermal patch
US5088977A (en)	1988-12-21	1992-02-18	Drug Delivery Systems Inc.	Electrical transdermal drug applicator with counteractor and method of drug delivery
US5236838A (en)	1988-12-23	1993-08-17	Genzyme Corporation	Enzymatically active recombinant glucocerebrosidase
US6451600B1 (en)	1989-12-22	2002-09-17	Genzyme Corporation	Enzymatically active recombinant glucocerebrosidase
US5096815A (en)	1989-01-06	1992-03-17	Protein Engineering Corporation	Generation and selection of novel dna-binding proteins and polypeptides
US5198346A (en)	1989-01-06	1993-03-30	Protein Engineering Corp.	Generation and selection of novel DNA-binding proteins and polypeptides
US5179023A (en)	1989-03-24	1993-01-12	Research Corporation Technologies, Inc.	Recombinant α-galactosidase a therapy for Fabry disease
US5328470A (en)	1989-03-31	1994-07-12	The Regents Of The University Of Michigan	Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
DK0494955T3 (da)	1989-10-05	1998-10-26	Optein Inc	Cellefri syntese og isolering af hidtil ukendte gener og polypeptider
DK0431519T3 (da)	1989-12-04	1994-07-04	Searle & Co	System til transdermal indgivelse af albuterol
US5747334A (en)	1990-02-15	1998-05-05	The University Of North Carolina At Chapel Hill	Random peptide library
US5401650A (en)	1990-10-24	1995-03-28	The Mount Sinai School Of Medicine Of The City University Of New York	Cloning and expression of biologically active α-galactosidase A
US5747469A (en)	1991-03-06	1998-05-05	Board Of Regents, The University Of Texas System	Methods and compositions comprising DNA damaging agents and p53
US6410010B1 (en)	1992-10-13	2002-06-25	Board Of Regents, The University Of Texas System	Recombinant P53 adenovirus compositions
CA2108144A1 (en)	1991-03-06	1992-09-07	Jack A. Roth	Methods and compositions for the selective inhibition of gene expression
US5352456A (en)	1991-10-10	1994-10-04	Cygnus Therapeutic Systems	Device for administering drug transdermally which provides an initial pulse of drug
US5252479A (en)	1991-11-08	1993-10-12	Research Corporation Technologies, Inc.	Safe vector for gene therapy
JPH07502219A (ja)	1991-12-18	1995-03-09	ミネソタ　マイニング　アンド　マニュファクチャリング　カンパニー	多重層型バリアー構造体
EP0553769B1 (de)	1992-01-29	1996-01-03	FRANZ VÖLKL GmbH & CO. SKI UND TENNIS SPORTARTIKELFABRIK KG	Ballspielschläger, insbesondere Tennisschläger
US5573905A (en)	1992-03-30	1996-11-12	The Scripps Research Institute	Encoded combinatorial chemical libraries
AU704183B2 (en)	1994-01-05	1999-04-15	Arqule, Inc.	Systematic modular production of aminimide- and oxazolone-based molecules having selected properties
US5705625A (en) *	1994-12-15	1998-01-06	The Johns Hopkins University School Of Medicine	Nucleic Acid Encoding novel protein tyrosine kinase
US5712171A (en)	1995-01-20	1998-01-27	Arqule, Inc.	Method of generating a plurality of chemical compounds in a spatially arranged array
EP0863984B1 (en)	1995-11-30	2006-05-10	The Board Of Regents, The University Of Texas System	Methods and compositions for the treatment of cancer
US6458574B1 (en)	1996-09-12	2002-10-01	Transkaryotic Therapies, Inc.	Treatment of a α-galactosidase a deficiency
US6083725A (en)	1996-09-13	2000-07-04	Transkaryotic Therapies, Inc.	Tranfected human cells expressing human α-galactosidase A protein
GB9623833D0 (en)	1996-11-16	1997-01-08	Zeneca Ltd	Chemical compound
US7419661B2 (en)	1997-04-30	2008-09-02	The Centre Of Excellence For Life Sciences Limited	Dermal sheath tissue in wound healing
AR013269A1 (es)	1997-08-04	2000-12-13	Scras	Producto que contiene por lo menos un rna de doble filamento combinado con por lo menos un agente anti-viral, para la utilizacion terapeutica en eltratamiento de una enfermedad viral, en especial de la hepatitis viral
US6210666B1 (en)	1997-10-21	2001-04-03	Orphan Medical, Inc.	Truncated α-galactosidase A to treat fabry disease
US6506559B1 (en)	1997-12-23	2003-01-14	Carnegie Institute Of Washington	Genetic inhibition by double-stranded RNA
JP2004504259A (ja) *	1998-06-30	2004-02-12	パーカー　ヒューズ　インスティテュート	Ｊａｋ−３インヒビターを用いたｃ−ｊｕｎ発現の阻害方法
GB9827152D0 (en)	1998-07-03	1999-02-03	Devgen Nv	Characterisation of gene function using double stranded rna inhibition
EP2314700A1 (en)	1999-01-28	2011-04-27	Medical College of Georgia Research Institute, Inc	Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
DE19956568A1 (de)	1999-01-30	2000-08-17	Roland Kreutzer	Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
US7015218B1 (en) *	1999-02-10	2006-03-21	Mitsubishi Pharma Corporation	Amide compounds and medicinal use thereof
WO2001029058A1 (en)	1999-10-15	2001-04-26	University Of Massachusetts	Rna interference pathway genes as tools for targeted genetic interference
GB9925964D0 (en)	1999-11-03	1999-12-29	Jahoda Colin A B	Hair transplantation
GB9927444D0 (en)	1999-11-19	2000-01-19	Cancer Res Campaign Tech	Inhibiting gene expression
US6188045B1 (en)	2000-04-03	2001-02-13	Alto-Shaam, Inc.	Combination oven with three-stage water atomizer
IES20010386A2 (en)	2000-04-20	2001-11-14	Bernard Mcnamara	A swimming pool assembly
US20020173478A1 (en)	2000-11-14	2002-11-21	The Trustees Of The University Of Pennsylvania	Post-transcriptional gene silencing by RNAi in mammalian cells
US7294504B1 (en)	2001-12-27	2007-11-13	Allele Biotechnology & Pharmaceuticals, Inc.	Methods and compositions for DNA mediated gene silencing
US7122552B2 (en) *	2002-05-30	2006-10-17	Vertex Pharmaceuticals Incorporated	Inhibitors of JAK and CDK2 protein kinases
US7148342B2 (en)	2002-07-24	2006-12-12	The Trustees Of The University Of Pennyslvania	Compositions and methods for sirna inhibition of angiogenesis
ES2387617T3 (es)	2002-11-14	2012-09-27	Aderans Research Institute, Inc.	Cultivo de células inductoras de cabello
WO2004063715A2 (en)	2003-01-10	2004-07-29	The Trustees Of Columbia University In The City Of New York	Methods of using crystal structure of carboxyltransferase domain of acetyl-coa carboxylase, modulators thereof, and computer methods
KR20070006889A (ko) *	2004-05-03	2007-01-11	노파르티스 아게	Ｓ1ｐ 수용체 작용제 및 ｊａｋ3 키나제 억제제를 포함하는조합물
KR20080051113A (ko)	2005-05-02	2008-06-10	콜드스프링하버러보러토리	Ｍｉｒ 17-92 클러스터를 이용한 암 진단용 조성물 및 방법
US20070041905A1 (en) *	2005-08-19	2007-02-22	Hoffman Rebecca S	Method of treating depression using a TNF-alpha antibody
US8404653B2 (en)	2005-11-14	2013-03-26	Enterprise Partners Venture Capital	Membrane bound stem cell factor therapy for ischemic heart
DE602006019916D1 (de)	2005-12-12	2011-03-10	Canji Inc	Adenovirale expressionsvektoren mit einer expressionskassette im e1-bereich und einer inaktivierten e2b-polymerase
AR060316A1 (es) *	2006-01-17	2008-06-11	Vertex Pharma	Azaindoles de utilidad como inhibidores de janus quinasas
AU2007220047B2 (en) *	2006-02-28	2013-08-01	Ym Biosciences Australia Pty Ltd	Inhibition of JAK2 as a treatment of pulmonary arterial hypertension
EP2007877B1 (en)	2006-02-28	2013-04-17	The Trustees of Columbia University in the City of New York	Methods for compact aggregation of dermal cells
GB0605691D0 (en) *	2006-03-21	2006-05-03	Novartis Ag	Organic Compounds
US7704533B2 (en) *	2006-12-13	2010-04-27	J&J Consumer Companies, Inc.	Compositions and methods of inducing hair growth utilizing Continus coggygria
US8871753B2 (en) *	2008-04-24	2014-10-28	Incyte Corporation	Macrocyclic compounds and their use as kinase inhibitors
CA2752150A1 (en) *	2009-02-11	2010-08-19	Reaction Biology Corp.	Selective kinase inhibitors
PL2635299T3 (pl) *	2010-11-02	2020-03-31	The Trustees Of Columbia University In The City Of New York	Sposoby leczenia zaburzeń utraty włosów

2013
- 2013-03-29 PL PL13769804T patent/PL2830662T3/pl unknown
- 2013-03-29 EP EP18188102.0A patent/EP3459565A1/en not_active Withdrawn
- 2013-03-29 ES ES13769804.9T patent/ES2694681T3/es active Active
- 2013-03-29 HU HUE13769804A patent/HUE040127T2/hu unknown
- 2013-03-29 SI SI201331215T patent/SI2830662T1/sl unknown
- 2013-03-29 JP JP2015503662A patent/JP6212107B2/ja active Active
- 2013-03-29 HR HRP20181976TT patent/HRP20181976T1/hr unknown
- 2013-03-29 KR KR1020147030281A patent/KR102135601B1/ko active Active
- 2013-03-29 WO PCT/US2013/034688 patent/WO2013149194A1/en not_active Ceased
- 2013-03-29 EP EP13769804.9A patent/EP2830662B1/en active Active
- 2013-03-29 CN CN201380027870.1A patent/CN104334191A/zh active Pending
- 2013-03-29 PT PT13769804T patent/PT2830662T/pt unknown
- 2013-03-29 DK DK13769804.9T patent/DK2830662T3/da active
2017
- 2017-09-14 JP JP2017176433A patent/JP6527565B2/ja active Active

Also Published As

Publication number	Publication date
EP2830662B1 (en)	2018-08-29
KR102135601B1 (ko)	2020-07-20
JP2018027959A (ja)	2018-02-22
KR20140148459A (ko)	2014-12-31
ES2694681T3 (es)	2018-12-26
HUE040127T2 (hu)	2019-02-28
JP6212107B2 (ja)	2017-10-11
EP2830662A4 (en)	2015-09-09
JP6527565B2 (ja)	2019-06-05
CN104334191A (zh)	2015-02-04
HRP20181976T1 (hr)	2019-01-25
EP3459565A1 (en)	2019-03-27
WO2013149194A1 (en)	2013-10-03
SI2830662T1 (sl)	2019-01-31
EP2830662A1 (en)	2015-02-04
PT2830662T (pt)	2018-11-29
JP2015515470A (ja)	2015-05-28
DK2830662T3 (da)	2019-01-02

Publication	Publication Date	Title
PL2830662T3 (pl)	2019-02-28	Sposoby leczenia zaburzeń utraty włosów
HUE045869T2 (hu)	2020-01-28	Módszerek hajhullásos rendellenességek kezelésére
PL2911548T3 (pl)	2018-06-29	Urządzenie do wykonywania zabiegów na włosach
GB2513074B (en)	2020-05-06	Treated apertures
GB2555310B (en)	2018-07-18	Hair styling apparatus
ZA201405831B (en)	2015-11-25	Hair styling apparatus
EP2907501A4 (en)	2016-04-20	BEAUTY CARE PROCESS
ZA201408353B (en)	2016-09-28	Method of treating hair
HUE044816T2 (hu)	2019-11-28	Készítmények és eljárások hajhullás kezelésére
ZA201408342B (en)	2016-09-28	Method of treating hair
EP2907500A4 (en)	2016-04-20	BEAUTY CARE PROCESS
IL227768A0 (en)	2013-09-30	Brain injury treatment methods
ZA201408343B (en)	2016-02-24	Method of treating hair
ZA201405161B (en)	2015-12-23	Hair treatment composition
IL237449A0 (en)	2015-04-30	Methods for treating health conditions related to hair
GB2497886B (en)	2014-04-23	Hair treatment methods
PL2861242T3 (pl)	2019-04-30	Zaburzenia związane z glutenem
EP2699245A4 (en)	2014-12-10	TREATMENT AGAINST HAIR LOSS
GB201207454D0 (en)	2012-06-13	Hair waving apparatus
GB201205911D0 (en)	2012-05-16	Hair treatment method
IL238363A0 (en)	2015-06-30	Methods for treating eye diseases
GB2500999B (en)	2014-02-26	Hair treatment methods
EP2854774A4 (en)	2015-11-18	METHODS OF TREATING INSOMNIA
GB201212604D0 (en)	2012-08-29	New treatment
GB201214387D0 (en)	2012-09-26	Methods for treating plants